RedHill Biopharma (RDHL) EBT Margin (2012 - 2023)
RedHill Biopharma (RDHL) reported EBT Margin of 4482.35% for Q2 2023, up 444628.0% year-over-year from N/an in Q2 2022, and up 2137.12% quarter-over-quarter from 220.03% in Q1 2023.
RedHill Biopharma (RDHL) EBT Margin (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has 11 years of EBT Margin data on file, last reported at 4482.35% in Q2 2023.
- EBT Margin for Q2 2023 came in at 4482.35%, up 444628.0% year-over-year; the trailing twelve-month figure through Jun 2023 was 225.21% (up 21641.0% YoY), and the FY2025 annual result was 2825.17%, down 282965.0% from the prior year.
- EBT Margin improved to 4482.35% in Q2 2023 per RDHL's latest filing, from 220.03% in the prior quarter.
- Over five years, EBT Margin peaked at 4482.35% in Q2 2023 and troughed at 658.14% in Q4 2021.
- A 5-year average of 436.26% and a median of 68.07% in 2020 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2021 and 2023: EBT Margin sank 149195 bps in 2021, then soared 444628 bps in 2023.
- A 5-year view of EBT Margin shows it stood at 728.11% in 2019, then plunged by 90 bps to 70.61% in 2020, then slumped by 1032 bps to 658.14% in 2021, then gained by 7 bps to 611.2% in 2022, then jumped by 833 bps to 4482.35% in 2023.
- Business Quant data shows RDHL's EBT Margin at 4482.35% in Q2 2023, 220.03% in Q1 2023, and 611.2% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -156.77% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 41.45% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.70% |
| 10 | RedHill Biopharma | 142.34 Mn | 142.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4,482.35% |
| Mar 31, 2023 | -220.03% |
| Dec 31, 2022 | -611.20% |
| Sep 30, 2022 | -94.71% |
| Jun 30, 2022 | 36.07% |
| Mar 31, 2022 | 97.22% |
| Dec 31, 2021 | -658.14% |
| Sep 30, 2021 | 62.23% |
| Jun 30, 2021 | 96.12% |
| Mar 31, 2021 | 65.53% |
| Dec 31, 2020 | 70.61% |
| Sep 30, 2020 | 50.51% |
| Jun 30, 2020 | 43.86% |
| Mar 31, 2020 | 1,557.48% |
| Dec 31, 2019 | 728.11% |
| Sep 30, 2019 | 767.88% |
| Jun 30, 2019 | 886.24% |
| Mar 31, 2019 | 492.57% |
| Dec 31, 2018 | 889.48% |
| Sep 30, 2018 | 436.08% |